Tibet Rhodiola Pharmaceutical Holding

Tibet Rhodiola Pharmaceutical Holding Inventory

The Inventory of Tibet Rhodiola Pharmaceutical Holding (600211.SS) as of Nov 3, 2026 is 181.27 M CNY. In the previous year, Inventory was 134.19 M CNY — a change of 35.08% (higher).

Inventory

181.27 MCNY

YoY

35.08%

Last updated:

Inventory of Tibet Rhodiola Pharmaceutical Holding is 2025 181.27 M CNY. Inventory of Tibet Rhodiola Pharmaceutical Holding was 2024 134.19 M CNY. It decreases by 35.08% higher compared to the previous year.

The Tibet Rhodiola Pharmaceutical Holding Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
62.27 M CNY
Jan 1, 2019
74.60 M CNY
Jan 1, 2020
70.86 M CNY
Jan 1, 2021
137.32 M CNY
Jan 1, 2022
99.95 M CNY
Jan 1, 2023
111.44 M CNY
Jan 1, 2024
134.19 M CNY
Jan 1, 2025
181.27 M CNY
The Tibet Rhodiola Pharmaceutical Holding Inventory history
YEARInventoryYoY
181.27 MCNY+35.08%
134.19 MCNY+20.42%
111.44 MCNY+11.49%
99.95 MCNY-27.21%
137.32 MCNY+93.80%
70.86 MCNY-5.03%
74.60 MCNY+19.80%
62.27 MCNY-28.14%
86.65 MCNY-8.05%
94.24 MCNY-25.28%
126.13 MCNY-58.71%
305.48 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tibet Rhodiola Pharmaceutical Holding Stock analysis

What does Tibet Rhodiola Pharmaceutical Holding do? Tibet Rhodiola Pharmaceutical Holding Co. generates revenue through the manufacture and wholesale of pharmaceutical products. The company distributes proprietary drug products and processes pharmaceuticals, serving markets across South China, North China, East China, Central China, and overseas regions. Its primary customers are pharmaceutical distributors and healthcare providers within these regions, focusing on the distribution of its proprietary drug portfolio. The firm's revenue streams are derived from the wholesale of manufactured pharmaceuticals and the processing of pharmaceutical products. It operates through a network of distributors in key Chinese regions and overseas markets, targeting healthcare institutions and pharmacies that require its proprietary drug solutions. The company's business model emphasizes regional distribution networks to reach its target segments efficiently. Tibet Rhodiola Pharmaceutical Holding Co. relies on its proprietary drug products for sales, with a strong presence in multiple Chinese regions and overseas markets. The company's revenue is driven by the distribution of these products through its established wholesale channels, catering to the healthcare sector's demand for pharmaceutical solutions in its operational areas. Tibet Rhodiola Pharmaceutical Holding is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tibet Rhodiola Pharmaceutical Holding stock

Inventory of Tibet Rhodiola Pharmaceutical Holding is 181.27 M CNY in 2025.

Inventory of Tibet Rhodiola Pharmaceutical Holding changed from 134.19 M CNY to 181.27 M CNY, representing a 35.08% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Tibet Rhodiola Pharmaceutical Holding since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Tibet Rhodiola Pharmaceutical Holding historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Tibet Rhodiola Pharmaceutical Holding

All Key Metrics — Tibet Rhodiola Pharmaceutical Holding